---
title: "Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294366263.md"
description: "On CNBC's Mad Money, Jim Cramer recommended buying Astera Labs (ALAB) ahead of earnings but expressed little interest in Rigetti Computing (RGTI). He described Eli Lilly (LLY) as a 'good company' suitable for long-term holding rather than trading. Additionally, HSBC initiated coverage on MakeMyTrip (MMYT) with a Buy rating and $70 price target."
datetime: "2026-07-30T12:15:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294366263.md)
  - [en](https://longbridge.com/en/news/294366263.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294366263.md)
---

# Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stock

On CNBC’s “Mad Money Lightning Round,” **Jim Cramer** said **Astera Labs, Inc.** (NASDAQ:ALAB) is a buy.

Astera Labs will release its financial results for the second quarter after the closing bell on Tuesday, Aug. 4. Analysts expect the company to report quarterly earnings of 69 cents per share on revenue of $360.56 million.

Cramer said **Rigetti Computing, Inc** (NASDAQ:RGTI) is the one he doesn’t “really care for.”

As per recent news, Rigetti Computing, on Monday, expanded its collaboration with **Hewlett Packard Enterprise Co.** (NYSE:HPE) and the Pittsburgh Supercomputing Center.

“**Eli Lilly** (NYSE:LLY) is classic own don’t trade,” Cramer said. “Eli Lilly is a good company, and I’ve owned it for years. I’m going to continue to own it for years because it’s a great business with great drugs.”

Eli Lilly, on July 23, reported topline results from two pivotal Phase 3 trials for its investigational triple-hormone agonist, retatrutide.

Cramer said he doesn’t know **MakeMyTrip Limited** (NASDAQ:MMYT).

On July 2, HSBC initiated coverage on MakeMyTrip with a Buy rating and announced a price target of $70.

**Price Action:**

-   Astera Labs shares fell 4% to settle at $249.74 on Wednesday.
-   Rigetti Computing shares dipped 9% to close at $13.22 during the session.
-   MakeMyTrip shares gained 6.4% to settle at $57.15 on Wednesday.
-   Eli Lilly shares fell 0.9% to close at $1,210.02.

_Photo via Shutterstock_

### Related Stocks

- [RGTI.US](https://longbridge.com/en/quote/RGTI.US.md)
- [MMYT.US](https://longbridge.com/en/quote/MMYT.US.md)
- [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [ELIS.US](https://longbridge.com/en/quote/ELIS.US.md)
- [RGTX.US](https://longbridge.com/en/quote/RGTX.US.md)
- [RGTU.US](https://longbridge.com/en/quote/RGTU.US.md)
- [LABX.US](https://longbridge.com/en/quote/LABX.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [RGTZ.US](https://longbridge.com/en/quote/RGTZ.US.md)
- [LLYZ.US](https://longbridge.com/en/quote/LLYZ.US.md)
- [HPE.US](https://longbridge.com/en/quote/HPE.US.md)
- [HSBC.US](https://longbridge.com/en/quote/HSBC.US.md)
- [RGTIW.US](https://longbridge.com/en/quote/RGTIW.US.md)
- [HPE-C.US](https://longbridge.com/en/quote/HPE-C.US.md)
- [DTIW.SG](https://longbridge.com/en/quote/DTIW.SG.md)
- [00005.HK](https://longbridge.com/en/quote/00005.HK.md)
- [HSBA.UK](https://longbridge.com/en/quote/HSBA.UK.md)

## Related News & Research

- [Lilly, Resilience to invest $750 million in US drug manufacturing expansion](https://longbridge.com/en/news/294370095.md)
- [HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%](https://longbridge.com/en/news/293701781.md)
- [First Trust Advisors LP Acquires 1,305 Shares of Eli Lilly and Company $LLY](https://longbridge.com/en/news/293719299.md)
- [Lilly Targets Early 2027 Filing for Next Obesity Drug](https://longbridge.com/en/news/293649982.md)
- [Cardiovascular disease biotech Scribe Therapeutics prices upsized IPO at $15, the high end of the range](https://longbridge.com/en/news/293756130.md)